The Venture Codex Logo

The Venture Codex

Camford Capital

435 Tasso St Ste 225, Palo Alto, California, 94301, United States

Overview

Venture capital firm investing in various sectors including FinTech.

Deals ยท 12mo

0

Links

WebsiteLinkedInX (Twitter)

Stage focus

Seed
Series A
Series B

Geographic focus

United States

Sector focus

Biotechnology
Enterprise Software
FinTech
Venture Capital

Investment portfolio

9rounds
NAMEDATESIZE
Totus Medicines
Dec 2023Participated
$66 MSeries B
SURGE Therapeutics
Jul 2023Participated
$32 MSeries B
FEDML
Jul 2023Led
$12 MSeed
Lavita
May 2023Led
$5 MSeed
Vevo Therapeutics
Dec 2022Participated
$12 MSeed
SURGE Therapeutics
Oct 2022Led
$26 MSeries A
Carbon Biosciences
Jun 2022Participated
$38 MSeries A
Strand Therapeutics
Jun 2021Participated
$52 MSeries A
CG Oncology
Dec 2020Participated
$47 MSeries D
Totus Medicines
Dec 2023Participated
$66 MSeries B
SURGE Therapeutics
Jul 2023Participated
$32 MSeries B
FEDML
Jul 2023Led
$12 MSeed
Lavita
May 2023Led
$5 MSeed
Vevo Therapeutics
Dec 2022Participated
$12 MSeed
SURGE Therapeutics
Oct 2022Led
$26 MSeries A
Carbon Biosciences
Jun 2022Participated
$38 MSeries A
Strand Therapeutics
Jun 2021Participated
$52 MSeries A
CG Oncology
Dec 2020Participated
$47 MSeries D
9
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Camford Capital: 9 funding rounds are recorded in the selected participation categories.All available history.
Camford Capital: 9 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Seed21
Series A12
Series B02
Series C+01

Monthly Deal Activity

Camford Capital: 9 deals are recorded across 71 months.All available history.
Camford Capital: 9 deals are recorded across 71 months. All available history
MonthDeals
Dec '201
Jan '210
Feb '210
Mar '210
Apr '210
May '210
Jun '211
Jul '210
Aug '210
Sep '210
Oct '210
Nov '210
Dec '210
Jan '220
Feb '220
Mar '220
Apr '220
May '220
Jun '221
Jul '220
Aug '220
Sep '220
Oct '221
Nov '220
Dec '221
Jan '230
Feb '230
Mar '230
Apr '230
May '231
Jun '230
Jul '232
Aug '230
Sep '230
Oct '230
Nov '230
Dec '231
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Camford Capital: Health & Life Sciences is the largest displayed sector by deal count (8 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Camford Capital: Health & Life Sciences is the largest displayed sector by deal count (8 deals). All available history
SectorDeals
Health & Life Sciences8
AI & Machine Learning3
Crypto & Blockchain2
Consumer & Lifestyle1

Deal Size Distribution

Camford Capital: 9 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Camford Capital: 9 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M1
$10M-$25M2
$25M-$50M4
$50M-$100M2
$100M-$250M0
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Camford Capital: United States has the largest recorded deal count among the displayed regions (9 deals).All available history.

Top 1 of 1 regions; European countries are grouped as Europe.

Camford Capital: United States has the largest recorded deal count among the displayed regions (9 deals). All available history
RegionDeals
United States9
Camford Capital: 20 co-investors are shown, with 8VC sharing 2 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Camford Capital: 20 co-investors are shown, with 8VC sharing 2 recorded deals. All available history
Co-investorShared deals
8VC2
Alumni Ventures2
Cancer Research Institute2
Intuitive Ventures2
Khosla Ventures2
Pitango HealthTech2
Agent Capital1
AIX Ventures1
ANRI1
Astellas Venture Management1
BeiGene1
Bioluminescence Ventures1
Cystic Fibrosis Foundation1
DCVC Bio1
Finality Capital1
General Catalyst1
KdT Ventures1
Kissei Pharmaceutical1
Longwood Fund1
Mubadala Capital1

Investment Strategy

Camford Capital: Led accounts for 33% and participating for 67% of round participation.All available history.
Camford Capital: Led accounts for 33% and participating for 67% of round participation. All available history
CategoryDeals (count)Share (%)
Led333%
Participating667%
Camford Capital: Single-lead accounts for 100% and co-led for 0% of lead dynamics.All available history.
Camford Capital: Single-lead accounts for 100% and co-led for 0% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead3100%
Co-led00%

Team

Ali Farahanchi

Partner

Poorya Hosseini

Partner